Status:
COMPLETED
A Comparison of the Effects of Tiotropium Inhalation qd and Salmeterol Inhalation Bid on Arterial Blood Gases.
Lead Sponsor:
Boehringer Ingelheim
Conditions:
Pulmonary Disease, Chronic Obstructive
Eligibility:
All Genders
50+ years
Phase:
PHASE3
Brief Summary
To evaluate changes in PaO2 following inhalation of Tiotropium by HandiHaler compared to Salmeterol MDI in patients with moderate to severe COPD.
Eligibility Criteria
Inclusion
Exclusion
Key Trial Info
Start Date :
December 1 2000
Trial Type :
INTERVENTIONAL
End Date :
July 1 2003
Estimated Enrollment :
36 Patients enrolled
Trial Details
Trial ID
NCT00274534
Start Date
December 1 2000
End Date
July 1 2003
Last Update
November 5 2013
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Hines Veterans Administration Hospital
Hines, Illinois, United States
2
Hunter Holmes McGuire Medical Center
Richmond, Virginia, United States